# Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN

> **NCT00831909** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3513 (actual)

## Conditions studied

- NSCLC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00831909
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 3513 (ACTUAL)
- **Last updated:** 2010-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831909, "Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00831909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*